Drugs / TAK-577
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT06173024 | — | von Willebrand disease (hereditary or acquired) | Takeda | Available | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TAK-577 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06173024 ↗ |
| Route | Intravenous | “All participants will receive TAK-577 as a sequential intravenous infusion based on their weight.” NCT06173024 ↗ |